GWPH up +1.57% percent Today $GWPH High is at 77.20 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
GWPH up +1.57% percent Today $GWPH High is at 77.20 and the Low 74.75 with current volume of 63,889.

Recent News posted below.

Gw Pharmaceuticals Plc Ads GWPH other info.
http://investorshangout.com/GW-Pharmaceuticals-GWPH-62459/

GWPH Gw Pharmaceuticals Plc Ads Recent Headline News

Why GW Pharmaceuticals (GWPH) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:46AM CST
GW Pharmaceuticals has decent short-term momentum and is also seeing solid activity on the earnings estimate revision front for the coming quarter and year.
GWPH: 75.46 (+0.14)

Allscripts Healthcare and CHI Sign Hosting Solution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 12:40PM CST
By utilizing Allscripts Healthcare Solutions, Inc. (MDRX) Hosting Solution, Catholic Health Initiatives expects improved system availability, reduced IT infrastructure expenditures as well as enhanced end user performance.
GWPH: 75.46 (+0.14), ABAX: 55.12 (+0.92), MDRX: 12.35 (+0.40), MRGE: 3.15 (+0.02)

INSYS Therapeutics (INSY) in Focus: Stock Rises 12% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:44AM CST
INSYS Therapeutics, Inc. (INSY) was a big mover last session, as the company saw its shares surge 12%
ICUI: 84.00 (-0.73), INSY: 38.14 (-1.51), ABAX: 55.12 (+0.92), GWPH: 75.46 (+0.14)

Omeros (OMER) Catches Eye: Stock Jumps 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:30AM CST
Omeros Corporation (OMER) was a big mover last session, as the company saw its shares rise almost 9% on the day.
ABAX: 55.12 (+0.92), GWPH: 75.46 (+0.14), OSUR: 9.06 (-0.12), OMER: 19.30 (-0.41)

Insys Q3 Beats Estimates, Helping Stock Rebound
at Investor's Business Daily - Tue Nov 11, 10:33AM CST
Specialty drugmaker Insys Therapeutics (INSY) beat Wall Street's Q3 estimates Tuesday, sending the stock up around 6% in early trading on the stock market today. Insys' revenue in the quarter totaled $58.3 million, double the year-earlier quarter and...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14), TEVA: 57.96 (-0.48), GSK: 45.72 (+0.10)

CannLabs; Growing a Presence in a Burgeoning Industry
ACCESSWIRE - Tue Nov 11, 8:56AM CST
WHITEFISH, MT / ACCESSWIRE / November 11, 2014 / The U.S. cannabis industry could reach between $21 billion and $35 billion by 2020, according to Green Wave Advisors, depending on the number of states that successfully legalize the drug over the coming years. As more states implement their own programs, there is a growing need for high-quality testing services in order to ensure high-quality and safe products for both medical and recreational users.
GWPH: 75.46 (+0.14)

Eagle Pharmaceuticals (EGRX) Jumps: Stock Gains 8.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:46AM CST
Eagle Pharmaceuticals (EGRX) was a big mover last session, with shares rising over 8% on the day.
ICUI: 84.00 (-0.73), ABAX: 55.15 (+0.95), GWPH: 75.46 (+0.14), EGRX: 12.75 (-0.05)

Cannabis Legalization Wins Out in Midterm Elections
ACCESSWIRE - Mon Nov 10, 10:00AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Cannabis stocks moved lower over the past week, according to data from the MarijuanaIndex(TM), despite favorable outcomes in the mid-term elections. Industry bellwethers, like GW Pharmaceuticals plc (NASDAQ: GWPH), traded largely sideways, although MedBox Inc. (OTC: MDBX) fell more than 20%.
GWPH: 75.46 (+0.14)

Cannabix Marijuana Breathalyzer Could Help Separate Users From Impaired
ACCESSWIRE - Mon Nov 10, 8:48AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Federal Schedule I regulations on medical marijuana (MMJ) and recreational use are changing with each passing day as states continue to hammer out their own policy frameworks, spurred on by sizeable additions to state coffers as a result of tax revenues. Pew Research Center survey data from earlier this year also shows that for the first time since 1969, when only 12% of Americans favored legalization, more than half (54%) the country is now in favor of making marijuana legal. With 23 states and D.C. now having either some form of MMJ legislation, or open recreational use on the books (as in Colorado and Washington), cash-strapped state budget makers are likely looking closely at data points like the Denver Business Journal's analysis of Colorado's recreational market, which forecasts around $70M in tax revenues this fiscal year. In Oregon, where a ballot vote for legalization is set to take place in November, the state's Legislative Revenue Office estimates 2017 tax revenues at around $16M as a result. Recent in-depth analysis by NerdWallet even put the upper limit for Oregon around $100M per annum, and with a nationwide projection of as much as $3.1B, it seems clear that the tax revenue factor could lead to more easing from the feds. On November 4th, Washington D.C. voters looked to join Colorado and Washington State in legalizing adult-use marijuana after backing Initiative 71 at the voting booths. With voters backing the bill 7-to-3, the initiative will permit anyone over the age of 21 to legally possess as much as two ounces of marijuana and to grow up to three marijuana plants at home.
GWPH: 75.46 (+0.14)

Meridian Bioscience (VIVO) Falls: Stock Goes Down 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:55AM CST
Meridian Bioscience saw a big move last session, as the company’s shares fell by nearly 6% which continued the recent downtrend
VIVO: 16.64 (-0.24), ABAX: 55.15 (+0.95), GWPH: 75.46 (+0.14), OSUR: 9.06 (-0.12)

Medical Marijuana Receives Mixed Signals With This Latest Study
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 09, 10:44AM CST
Source: Flickr user Matthew Kenwrick. The results of the midterm elections were mixed for supporters of marijuana legalization, though mostly positive. Hopes were high that the states of Oregon and Alaska, as well as Washington, D.C., would...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14)

The Important Lesson Learned From Florida's Medical Marijuana Vote
Sean Williams, The Motley Fool - Motley Fool - Sat Nov 08, 11:26AM CST
Source: Flickr user Mark. Midterm elections may be over, but that doesn't mean the number of issues that Congress and individual states are yet to tackle have been moved to the back burner. One particular hot-button issue that took center stage...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14)

3 Approve Marijuana Measures, but Florida Passes on Pot
Todd Campbell, The Motley Fool - Motley Fool - Sat Nov 08, 11:09AM CST
Source: Architect of the Capitol, Flickr. Marijuana advocates are cheering the approval of recreational marijuana in Oregon, Alaska, and the District of Columbia, but supporters in Florida will need to shift their focus to 2016. Marijuana is...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14), LVS: 63.01 (+1.44)

Allscripts Healthcare Q3 Earnings, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:30PM CST
Allscripts Healthcare Solutions, Inc. (MDRX) posted adjusted earnings of 2 cents per share in the third quarter of 2014 which missed the Zacks Consensus Estimate by 3 cents.
GWPH: 75.46 (+0.14), ABAX: 55.18 (+0.98), MDRX: 12.35 (+0.40), MRGE: 3.15 (+0.02)

Wright Medical Posts Wider Q3 Loss; Lowers '14 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:50AM CST
Following the earnings release, shares of Wright Medical Group Inc. (WMGI) dropped nearly 5.7% to close at $28.44 yesterday.
BSX: 13.38 (-0.03), WMGI: 28.59 (+0.39), GWPH: 75.46 (+0.14), ABAX: 55.18 (+0.98)

Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 84.00 (-0.73), ABAX: 55.18 (+0.98), GWPH: 75.46 (+0.14), HSP: 57.87 (-0.22)

Novus MedPlan Cost-Saving Provider Network Offers A Strong Value Proposition
ACCESSWIRE - Fri Nov 07, 8:01AM CST
WHITEFISH, MT / ACCESSWIRE / November 7, 2014 / Marijuana reform was a key ballot initiative in seven states (as well as 17 municipalities and D.C.) this week, with more drug policy reform questions (most aimed at reforming or out outright repealing marijuana laws) on the ballot than at any time in the history of the country. In California, Proposition 47 was passed, transforming the lowest-level non-violent crimes like simple drug possession, from a felony to a misdemeanor, freeing up an estimated $1B per annum to be dedicated to useful things like crime prevention, school funding, mental health treatment, and victim services. Regulatory reforms like this are opening up sizable markets for both private and public sector participants.
GWPH: 75.46 (+0.14)

Cannagrow Holdings, Inc. (CGRW) Establishes Itself As a Leader In Colorado's Expanding Cannabis Industry
ACCESSWIRE - Thu Nov 06, 7:01AM CST
Salt Lake City, UT / ACCESSWIRE / November 6, 2014 / As Cannagrow Holdings, Inc. (CGRW) further establishes itself in Colorado and strengthens its association with licensed cannabis growers in the region, cannabis measures voted into law on election day in several states should place CGRW in an ideal position to see substantial gains in a cannabis market that could prove to be far larger than anyone could have predicted over the next two to three years.
GWPH: 75.46 (+0.14)

Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 69.38 (+0.88), GWPH: 75.46 (+0.14), ABAX: 55.18 (+0.98), COV: 93.87 (+0.99)

Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:46AM CST
Sophiris Bio (SPHS) was a big mover last session, as the company saw its shares surge 25% on the day.
ICUI: 84.00 (-0.73), ABAX: 55.18 (+0.98), GWPH: 75.46 (+0.14), SPHS: 2.55 (-0.07)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cambrian Turns Dairy Wastewater Into Long-Term Gas

Updated Category News Views 52

A Wisconsin dairy plant just traded lagoon duty for a 20-year service arrangement, and that is more consequential than the usual shiny renewable-gas headline. Cambrian Innovation says it has commissioned and is operating a wastewater treatment and resource recovery system that handles roughly 280,000 gallons a day. That works out to about 102 million gallons annually, a...

Continue Reading
DocLinq Takes Aim at Care Gaps Between Office Visits

Updated Category News Views 182

Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...

Continue Reading
Skanska Adds $80M U.S. Tech Facility Contract to Orders

Updated Category News Views 149

An $80 million add-on is the sort of construction news that looks modest until you remember what it says about the customer relationship. Skanska has won an additional contract from an existing client for a U.S. tech facility, worth roughly SEK 760 million, and it will enter U.S. order bookings in the fourth quarter of 2026. No fireworks, no grand strategic...

Continue Reading
ZAKSIMLAB Tests Kombucha and Salmon Snack Pairing in Cafes

Updated Category News Views 202

A fish-based chip beside a fizzy tea mix is an odd little commercial wager, and that is exactly why ZAKSIMLAB's latest move deserves a look. The Seoul food brand launched Salmon Crunch Protein Chips in September, then put the snack next to its powdered kombucha at the 2026 Cafe & Bakery Fair Season 2. This is not a grand earnings story; no sales, pricing, store-count, or...

Continue Reading
MetaComp Targets ASEAN's Cross-Border Payment Snarl

Updated Category News Views 111

ASEAN payment plumbing is still a patchwork, and MetaComp is betting that patchwork has finally become painful enough to fix. The Singapore-based payments firm says its StableX Agentic Network has topped 1,000 members and reaches more than 100,000 users in its first year. That is a respectable early footprint, not a victory lap. Cross-border payments are littered with...

Continue Reading
Mantle's Japan Listing Puts $MNT Through a Real Test

Updated Category News Views 163

Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...

Continue Reading
Housing's Value Equation Is Getting More Complicated

Updated Category News Views 64

A homeowner's insurance bill has become a louder market signal than a granite countertop. Green Builder Media's latest batch of research, publishing and events is aimed squarely at that uncomfortable truth: housing is no longer judged only by the price on the contract. Buyers, builders, lenders and insurers are being pushed to reckon with what a home costs to own, protect...

Continue Reading
Freedom Debt Relief Earns Service Recognition in 2026

Updated Category News Views 0

A Service Badge Carries Weight in a Rough Business Debt settlement is not a business where a pleasant phone voice alone gets the job done. People arrive carrying unsecured balances, anxiety, and usually a fair amount of distrust. That is why CNBC Select naming Freedom Debt Relief its “Best for Customer Service” is more meaningful than the usual chest-thumping...

Continue Reading
BD&J's Workplace Recognition Meets Los Angeles Growth Test

Updated Category News Views 58

A workplace award is not a verdict from a jury, but it can still tell you where a law firm is putting its money and attention. BD&J Injury Lawyers landed on the Los Angeles Business Journal's 2026 list of most admired law firms to work for, announced November 18. For a personal-injury practice trying to deepen its footing in a brutally crowded Los Angeles market, that is...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 49

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading

Top 5 Most Recently Viewed Articles

Delta Air Lines and Taiwan Semiconductor: Earnings Insights

Updated Category News Views 120

Delta Air Lines: Anticipated Earnings Report As we look ahead to the earnings season, all eyes are on Delta Air Lines. Sales projections indicate a modest increase of 0.8%, yet analysts predict a significant downturn of 15.2% in earnings. Despite some downward adjustments from analysts, Delta boasts an impressive history of surprising on earnings. Delta operates multiple...

Continue Reading
Vera Bradley Sees Share Price Decline Amid Revenue Challenges

Updated Category News Views 153

Vera Bradley Experiences Revenue Challenges Amid Market Pressures Vera Bradley, Inc. (NASDAQ: VRA) has recently faced a noteworthy drop in its stock price, which sank by 12.65% in premarket trading. This decline followed the company's second-quarter earnings report that, although it surpassed expectations, revealed that revenue fell short of what analysts had predicted....

Continue Reading
Organon's Q4 Earnings Results: Key Highlights for Investors

Updated Category News Views 188

Understanding Organon's Q4 Earnings Results Organon (NYSE: OGN) has recently shared its earnings report, revealing critical insights that every investor should consider. The report reflects the company's financial health and performance trends over the last quarter, helping stakeholders make informed decisions. Earnings Overview In a notable announcement, Organon reported...

Continue Reading
Expanding Mental Health Services: Ana Deeter Joins Relief

Updated Category News Views 222

Expanding Mental Health Services at Relief Mental Health Relief Mental Health is excited to announce the addition of Ana Deeter, PA-C, to their team at the Northbrook clinic. Deeter, who is a board-certified physician assistant, will enhance the clinic's psychiatric services and offer SPRAVATO® (esketamine) treatment to adults seeking support. A New Specialist for...

Continue Reading
Discover BLUETTI's Cutting-Edge Energy Innovations at CES 2026

Updated Category News Views 245

Revolutionizing Energy Solutions with BLUETTI At this year's CES, BLUETTI, a leader in energy storage solutions, introduced an array of revolutionary products under the theme 'Innovate for All'. These innovations cater to the diverse demands of modern living, providing freedom and resilience for homes, vehicles, and the planet. Key Innovations from BLUETTI As BLUETTI...

Continue Reading